BRIEF-Cytori Therapeutics fully enrolls pivotal U.S. Phase III Scleroderma trial
May 25, 2016 at 07:29 AM EDT
* Cytori fully enrolls pivotal U.S. Phase III scleroderma trial Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)